1334167-86-0

Basic information

• Product Name: 6-Ethoxy-5-fluoropyridine-3-boronic acid pinacol ester
• Synonyms: 6-Ethoxy-5-fluoropyridine-3-boronic acid pinacol ester;2-Ethoxy-3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
• CAS NO: 1334167-86-0
• Molecular Formula: C13H19BFNO3
• Molecular Weight: 267.1042632
• Mol File: 1334167-86-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 336.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.10±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 1.59±0.34(Predicted)
• CAS DataBase Reference: 6-Ethoxy-5-fluoropyridine-3-boronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Ethoxy-5-fluoropyridine-3-boronic acid pinacol ester(1334167-86-0)
• EPA Substance Registry System: 6-Ethoxy-5-fluoropyridine-3-boronic acid pinacol ester(1334167-86-0)

Safety Data

• Hazardous Substances Data: 1334167-86-0(Hazardous Substances Data)

Usage

General Description

6-Ethoxy-5-fluoropyridine-3-boronic acid pinacol ester is a chemical compound that consists of a boronic acid group attached to a pyridine ring with an ethoxy and fluoro substituent. It is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals due to its ability to undergo cross-coupling reactions with other organic molecules. The pinacol ester moiety provides stability to the boronic acid, allowing for easier storage and handling. 6-Ethoxy-5-fluoropyridine-3-boronic acid pinacol ester has potential applications in medicinal chemistry and drug discovery due to its unique chemical structure and reactivity.

Upstream product

• 886373-94-0 5-chloro-2-ethoxy-3-fluoro-pyridine 
• 73183-34-3 bis(pinacol)diborane 
• 89402-43-7 5-chloro-2,3-difluoropyridine 

Relevant articles and documents

PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

The present invention relates to pyrrolidinone derivatives of formula (I). The pyrrolidinone derivatives of formula (I) are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

IMIDAZO [1, 2 -A] PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES

The present invention relates to novel imidazo[1,2-a]pyrazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.